Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01665
|
|||||
Drug Name |
Beclomethasone dipropionate
|
|||||
Synonyms |
BECLOMETHASONE DIPROPIONATE; Beclometasone dipropionate; Beconase; Beclovent; Vancenase; Beclorhinol; Becloforte; Sanasthmyl; Beclazone; Sanasthmax; Propaderm; Beclomet; Vanceril; Aerobec; Becloturmant; Beclacin; Respocort; Entyderma; Korbutone; Viarox; Rino-clenil; Clenil-A; Beclometasone 17,21-dipropionate; Becotide; Aldecin; Turbinal; Aldecina; Rhinosol; Beclate; Atomase; Alanase; Benconase; Aldecine; Clenil; Spir; Beclocort Nasel; Beclomet Nasal; Propaderm Forte; Rhino Clenil; Inalone O; Inalone R; Qvar; QNASL; Beconase AQ; Qvar 80
|
|||||
Indication | Allergic rhinitis [ICD11: CA08.0] | Phase 4 | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C28H37ClO7
|
|||||
Canonical SMILES |
CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC
|
|||||
InChI |
InChI=1S/C28H37ClO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1
|
|||||
InChIKey |
KUVIULQEHSCUHY-XYWKZLDCSA-N
|
|||||
CAS Number |
CAS 5534-09-8
|
|||||
Pharmaceutical Properties | Molecular Weight | 521 | Topological Polar Surface Area | 107 | ||
Heavy Atom Count | 36 | Rotatable Bond Count | 8 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 7 | |||
XLogP |
3
|
|||||
PubChem CID | ||||||
ChEBI ID |
CHEBI:3002
|
|||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | ClinicalTrials.gov (NCT02646904) Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis | |||||
2 | Oral and inhaled corticosteroids: differences in P-glycoprotein (ABCB1) mediated efflux. Toxicol Appl Pharmacol. 2012 May 1;260(3):294-302. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.